Galactosylated liposomes for targeted co-delivery of doxorubicin/vimentin siRNA to hepatocellular carcinoma

HR Oh, HY Jo, JS Park, DE Kim, JY Cho, PH Kim… - Nanomaterials, 2016 - mdpi.com
The combination of therapeutic nucleic acids and chemotherapeutic drugs has shown great
promise for cancer therapy. In this study, asialoglycoprotein receptors (ASGPR) targeting …

The challenge of regulating nanomedicine: Key issues

R Bawa, Y Barenholz, A Owen - 2016 - books.rsc.org
There is no shortage of excitement, exuberance, hype and misinformation when it comes to
anything ''nano''. Many claim it to be the next industrial revolution, some purport that it has …

Nanoparticle carriers to overcome biological barriers to siRNA delivery

HM Aliabadi, H Uludağ - 2016 - books.rsc.org
A different approach to traditional medicine, which commonly aims to control and/or
eliminate the symptoms of a disorder, or foreign organisms in the body, is to down-regulate …

Gene and cell therapy using cell fusion technology

S Jung-Joon, S Seong, LEE Hee-Woo… - US Patent 11,850,288, 2023 - Google Patents
A gene and cell therapy using a cell fusion technology is proposed. Cells overexpressing
hemagglutinin neuraminidase (HN) and fusion (F) proteins have effects of enhancing cell …

Gene and cell therapy using cell fusion technology

S Jung-Joon, S Seong, LEE Hee-Woo… - US Patent 11,077,207, 2021 - Google Patents
The present invention relates to gene and cell therapy using a cell fusion technology and
more particularly, cells overexpressing hemagglutinin neuraminidase (HN) and fusion (F) …

[PDF][PDF] Instructions for Book Chapter Proofs

BP Team - researchgate.net
A different approach to traditional medicine, which commonly aims to control and/or
eliminate the symptoms of a disorder, or foreign organisms in the body, is to down-regulate …